Indian pharma is moving from generics to specialty and innovation
Specialty, biosimilars, novel formulations and innovation pipelines are reshaping leadership briefs — R&D, regulatory and commercial roles all require new skill sets.
Clinical, scientific and commercial leadership for businesses where the outcome is human.
Healthcare and life sciences is the sector where the cost of a wrong leadership hire is measured in patient outcomes, not just shareholder returns. Our practice has spent two decades building the depth required to serve it.
We work with hospital chains, pharma majors, biotech innovators, medical-device companies, diagnostics chains and digital health platforms. Search in this sector demands equal fluency in clinical credibility, regulatory exposure and commercial outcomes.
The forces shaping leadership demand in Healthcare right now.
Specialty, biosimilars, novel formulations and innovation pipelines are reshaping leadership briefs — R&D, regulatory and commercial roles all require new skill sets.
PE capital is reshaping management benches across single-specialty and multi-specialty chains. CEO, COO, Medical Director and CFO roles are in continuous demand.
Both are among the fastest-growing healthcare segments in India and the GCC, and leadership benches are thin.
AI diagnostics, remote care, digital therapeutics and integrated platforms are creating CEO, CPO and Chief Medical Officer roles that did not exist five years ago.
"The best healthcare leaders combine clinical credibility, regulatory exposure and commercial outcomes. We balance all three from the first round of evaluation, not the last."
Representative roles across 5 role families.
We balance MBBS / MD / PhD credentials with proof of commercial scale — neither alone is enough at the leadership level.
USFDA, EMA, CDSCO, MOH — we know which exposures a role genuinely needs and which are nice-to-have, and we shortlist accordingly.
Tertiary, secondary, single-specialty and home-care chains all need different leaders. We don't substitute.
We back-channel reference candidates on patient outcomes and clinical-quality records before final rounds.
The way we run a sector search end to end.
We engage clinical leaders, founders and board members to define what the role must deliver for patients and for the P&L.
Targeted mapping across the exact sub-sector and care model — hospitals, devices, pharma, diagnostics or digital health.
Clinical peers, commercial peers, regulators and ex-team-members all consulted before final rounds.
Structured leadership interviewing with explicit focus on clinical integrity, patient-safety mindset and commercial discipline.
Compensation, relocation, regulatory licensing where applicable, and structured 90-day clinical-immersion plans.
We run integrated India–GCC–SEA mandates across hospital chains, pharma majors and medical-device businesses. Indian-origin clinical and commercial leaders are increasingly being placed in GCC and Singapore-based regional roles, and we maintain the candidate networks to support these moves.
Anonymised to protect client and candidate confidentiality.
Confidential replacement of a tenured CEO. Mapped 60 candidates across hospital majors; closed in 15 weeks.
Hired from a global pharma R&D leadership pool; relocated from Boston to Hyderabad.
Hired the first non-founder CEO. Compensation structured 40% cash / 60% equity, with founder-aligned ESOPs.
A sector lead from our Healthcare practice will be in touch within one business day.